These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34941672)

  • 1. New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency.
    Burgin D; Périer C; Hackett G; Elliott M; Kwan D; Hornby F; Mir I; Maignel J; Liu SM; Beard M
    Toxins (Basel); 2021 Nov; 13(12):. PubMed ID: 34941672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
    Hackett G; Moore K; Burgin D; Hornby F; Gray B; Elliott M; Mir I; Beard M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29751611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo.
    Donald S; Elliott M; Gray B; Hornby F; Lewandowska A; Marlin S; Favre-Guilmard C; Périer C; Cornet S; Kalinichev M; Krupp J; Fonfria E
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00446. PubMed ID: 30519475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
    Rummel A; Mahrhold S; Bigalke H; Binz T
    FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and biochemical characterization of light chains of Botulinum neurotoxin subtypes F5 and F7.
    Guo J; Chen S
    Protein Expr Purif; 2015 Jul; 111():87-90. PubMed ID: 25858313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S; Bradshaw M; Tepp WH; Pier CL; Whitemarsh RCM; Chen C; Barbieri JT; Johnson EA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").
    Pellett S; Tepp WH; Lin G; Johnson EA
    Toxicon; 2018 Jun; 147():38-46. PubMed ID: 29273248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Neurotoxin F Subtypes Cleaving the VAMP-2 Q
    Sikorra S; Skiba M; Dorner MB; Weisemann J; Weil M; Valdezate S; Davletov B; Rummel A; Dorner BG; Binz T
    Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30071628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative characterization of botulinum neurotoxin subtypes F1 and F7 featuring differential substrate recognition and cleavage mechanisms.
    Guo J; Chan EW; Chen S
    Toxicon; 2016 Mar; 111():77-85. PubMed ID: 26748154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test.
    Weisemann J; Krez N; Fiebig U; Worbs S; Skiba M; Endermann T; Dorner MB; Bergström T; Muñoz A; Zegers I; Müller C; Jenkinson SP; Avondet MA; Delbrassinne L; Denayer S; Zeleny R; Schimmel H; Åstot C; Dorner BG; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):5035-54. PubMed ID: 26703728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.
    Elliott M; Maignel J; Liu SM; Favre-Guilmard C; Mir I; Farrow P; Hornby F; Marlin S; Palan S; Beard M; Krupp J
    PLoS One; 2017; 12(10):e0185628. PubMed ID: 28982136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
    mSphere; 2016; 1(1):. PubMed ID: 27303710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin X lacks potency in mice and in human neurons.
    Gregg BM; Matsumura T; Wentz TG; Tepp WH; Bradshaw M; Stenmark P; Johnson EA; Fujinaga Y; Pellett S
    mBio; 2024 Mar; 15(3):e0310623. PubMed ID: 38347673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
    Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
    Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy.
    Yin L; Masuyer G; Zhang S; Zhang J; Miyashita SI; Burgin D; Lovelock L; Coker SF; Fu TM; Stenmark P; Dong M
    PLoS Biol; 2020 Mar; 18(3):e3000618. PubMed ID: 32182233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
    Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence diversity of genes encoding botulinum neurotoxin type F.
    Raphael BH; Choudoir MJ; Lúquez C; Fernández R; Maslanka SE
    Appl Environ Microbiol; 2010 Jul; 76(14):4805-12. PubMed ID: 20511432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells.
    Purkiss JR; Friis LM; Doward S; Quinn CP
    Neurotoxicology; 2001 Aug; 22(4):447-53. PubMed ID: 11577803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.